These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32598019)

  • 1. FGF23 and primary hyperparathyroidism: is there a link?
    Bilha SC; Gatu AA; Velicescu C; Bilha A; Florescu A; Branisteanu D
    Endokrynol Pol; 2020; 71(4):306-312. PubMed ID: 32598019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased circulating levels of FGF23: an adaptive response in primary hyperparathyroidism?
    Witteveen JE; van Lierop AH; Papapoulos SE; Hamdy NA
    Eur J Endocrinol; 2012 Jan; 166(1):55-60. PubMed ID: 21984611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum leptin, parathyroid hormone, 1,25-dihydroxyvitamin D, fibroblast growth factor 23, bone alkaline phosphatase, and sclerostin relationships in obesity.
    Grethen E; Hill KM; Jones R; Cacucci BM; Gupta CE; Acton A; Considine RV; Peacock M
    J Clin Endocrinol Metab; 2012 May; 97(5):1655-62. PubMed ID: 22362819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGF23, metabolic risk factors, and blood pressure in patients with primary hyperparathyroidism undergoing parathyroid adenomectomy.
    Nilsson IL; Norenstedt S; Granath F; Zedenius J; Pernow Y; Larsson TE
    Surgery; 2016 Jan; 159(1):211-7. PubMed ID: 26435425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced parathyroid hormone-stimulated 1,25-dihydroxyvitamin d production in vitamin d sufficient postmenoposual women with low bone mass and idiopathic secondary hyperparathyroidism.
    Streeten EA; Rogstad AS; Flammer KM; Zarbalian K; Ryan K; Horwitz M; Holick MF; Shelton J
    Endocr Pract; 2013; 19(1):91-9. PubMed ID: 23186957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism.
    Moosgaard B; Vestergaard P; Heickendorff L; Melsen F; Christiansen P; Mosekilde L
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):506-13. PubMed ID: 16268801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trial.
    Verheyen N; Fahrleitner-Pammer A; Pieske B; Meinitzer A; Belyavskiy E; Wetzel J; Gaksch M; Grübler MR; Catena C; Sechi LA; Van Ballegooijen AJ; Brandenburg VM; Scharnagl H; Perl S; Brussee H; März W; Pilz S; Tomaschitz A
    J Hypertens; 2016 Sep; 34(9):1778-86. PubMed ID: 27379537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of bone mass changes after successful parathyroidectomy using biochemical markers of bone metabolism in primary hyperparathyroidism: is it clinically useful?
    Ohe MN; Bonanséa TCP; Santos RO; Neves MCD; Santos LM; Rosano M; Kunii IS; Castro ML; Vieira JGH
    Arch Endocrinol Metab; 2019 Jul; 63(4):394-401. PubMed ID: 31365627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D in Primary Hyperparathyroidism: Effects on Clinical, Biochemical, and Densitometric Presentation.
    Walker MD; Cong E; Lee JA; Kepley A; Zhang C; McMahon DJ; Silverberg SJ
    J Clin Endocrinol Metab; 2015 Sep; 100(9):3443-51. PubMed ID: 26079779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone metabolism in patients with primary hyperparathyroidism before and after surgery.
    Kerschan-Schindl K; Riss P; Krestan C; Rauner M; Bieglmayer C; Gleiss A; Fialka-Moser V; Niederle B; Pietschmann P
    Horm Metab Res; 2012 Jun; 44(6):476-81. PubMed ID: 22495973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Characteristics of Primary Hyperparathyroidism: 15-Year Experience of 457 Patients in a Single Center in China.
    Lin X; Fan Y; Zhang Z; Yue H
    Front Endocrinol (Lausanne); 2021; 12():602221. PubMed ID: 33716964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does Baseline PTH Influence Recovery of Bone Mineral Density, Trabecular Bone Score and Bone Turnover Markers? A Prospective Study Following Curative PArathyroidectomy in Primary Hyperparathyroidism.
    Shetty S; Cherian KE; Shetty S; Kapoor N; Jebasingh FK; Cherian A; Hephzibah J; Chandramohan A; John RA; Asha HS; Paul MJ; Manipadam MT; Abraham DT; Thomas N; Paul TV
    Endocr Pract; 2020 Dec; 26(12):1442-1450. PubMed ID: 33471736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of an oral sodium phosphate load on parathyroid hormone and fibroblast growth factor 23 secretion in normo- and hypercalciuric stone-forming patients.
    Irzyniec T; Boryń M; Kasztalska J; Nowak-Kapusta Z; Maciejewska-Paszek I; Grochowska-Niedworok E
    Clin Nutr; 2020 Dec; 39(12):3804-3812. PubMed ID: 32386861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal PTH levels in primary hyperparathyroidism: still the same disease?
    Amin AL; Wang TS; Wade TJ; Yen TW
    Ann Surg Oncol; 2011 Nov; 18(12):3437-42. PubMed ID: 21537864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low vitamin D levels have become less common in primary hyperparathyroidism.
    Walker MD; Cong E; Lee JA; Kepley A; Zhang C; McMahon DJ; Bilezikian JP; Silverberg SJ
    Osteoporos Int; 2015 Dec; 26(12):2837-43. PubMed ID: 26084258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma 25-hydroxyvitamin D and not 1,25-dihydroxyvitamin D is associated with parathyroid adenoma secretion in primary hyperparathyroidism: a cross-sectional study.
    Moosgaard B; Vestergaard P; Heickendorff L; Melsen F; Christiansen P; Mosekilde L
    Eur J Endocrinol; 2006 Aug; 155(2):237-44. PubMed ID: 16868136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Serum Level of FGF23 and 1,25(OH)
    Hassani S; Afkhamizadeh M; Teimouri A; Najaf Najafi M; Vazifeh Mostaan L; Mohebbi M
    Int J Gen Med; 2020; 13():289-295. PubMed ID: 32606893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor 23, parathyroid hormone, and 1alpha,25-dihydroxyvitamin D in surgically treated primary hyperparathyroidism.
    Tebben PJ; Singh RJ; Clarke BL; Kumar R
    Mayo Clin Proc; 2004 Dec; 79(12):1508-13. PubMed ID: 15595334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of 25-hydroxyvitamin D deficiency on perioperative parathyroid hormone kinetics and results in patients with primary hyperparathyroidism.
    Untch BR; Barfield ME; Dar M; Dixit D; Leight GS; Olson JA
    Surgery; 2007 Dec; 142(6):1022-6. PubMed ID: 18063090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of vitamin D status on the relative increase in fibroblast growth factor 23 and parathyroid hormone in chronic kidney disease.
    Taal MW; Thurston V; McIntyre NJ; Fluck RJ; McIntyre CW
    Kidney Int; 2014 Aug; 86(2):407-13. PubMed ID: 24429404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.